"IU Health North Hospital is committed to serving the Carmel, Indiana, area."

During the past decade, IU Health North Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 19 clinical trials were completed, i.e. on average, 42.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 12 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health North Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Indiana University" with 7 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health North Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Indiana University" with 3 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "IU Health North Hospital" are "Breast Cancer" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage II Breast Cancer" (4 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials). Many other conditions were trialed in "IU Health North Hospital" in a lesser frequency.

Most popular intervention types in "IU Health North Hospital" are "Drug" (38 trials), "Other" (30 trials), "Procedure" (16 trials), "Biological" (14 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Laboratory Biomarker Analysis" (11 trials), "Questionnaire Administration" (9 trials), "Cisplatin" (8 trials) and "Biospecimen Collection" (7 trials). Other intervention names were less common.

The vast majority of trials in "IU Health North Hospital" are 50 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 39 active trials in "IU Health North Hospital". 1 are not yet recruiting, 14 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in IU Health North Hospital, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IU Health North Hospital, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

IU Health North Hospital has several departments that took part in Clinical trials: "Indiana University Health Neuroscience Center" - 17 trials